Interesting, page-3384

This.

IBX's offering is a unique one in that it if it's VP is fulfilled, it won't matter if the market is in deep decline.

IBX has several things going for it that many listed co's do not:
1) endless supply of global demand. Even if we find a cure for cancer, we still have to find it within each individual.
2) Printer ink model with high amazing margins.
3) Insurance-covered payments, and many countries offer government subsidies on medical expenditure = revenue stream is protected.
4) extremely high public goodwill.

Market flying or market falling, it's a billion $+. Look at a company like Amgen (AMGN) in the US... in 2008, they were +25%. They didn't do anything new, it's just that quite simply their offering of medical treatments could not be done without.

The primary concern for the investor is not the market, it's the validity of the offering. Right now, that validity is as clear as it can be.